StockData
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Turn Therapeutics Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.74+0.17 (+1.61%)

Close on Oct 19, 2026

Market cap
$319.92M
P/E (TTM)
–
Dividend yield
–

SEC filings

32 of Turn Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Proxy statementDEF 14ANov 30, 2026Oct 19, 2026SEC EDGAR
Current report8-KOct 6, 2026Oct 7, 2026SEC EDGAR
Current report8-KSep 10, 2026Sep 10, 2026SEC EDGAR
Current report8-KSep 9, 2026Sep 9, 2026SEC EDGAR
Current report8-KAug 13, 2026Aug 18, 2026SEC EDGAR
Current report8-KAug 14, 2026Aug 17, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 12, 2026SEC EDGAR
Current report8-KAug 12, 2026Aug 12, 2026SEC EDGAR
Current report8-KJul 28, 2026Jul 28, 2026SEC EDGAR
Current report8-KJul 7, 2026Jul 7, 2026SEC EDGAR
Current report8-KJun 3, 2026Jun 3, 2026SEC EDGAR
Current report8-KJun 1, 2026Jun 1, 2026SEC EDGAR
Current report8-KMay 27, 2026May 27, 2026SEC EDGAR
Current report8-KMay 19, 2026May 19, 2026SEC EDGAR
Current report8-KMay 18, 2026May 18, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 11, 2026SEC EDGAR
Current report8-KMay 11, 2026May 11, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 31, 2026SEC EDGAR
Current report8-KMar 31, 2026Mar 31, 2026SEC EDGAR
Current report8-KMar 23, 2026Mar 24, 2026SEC EDGAR
Current report8-KFeb 17, 2026Feb 17, 2026SEC EDGAR
Current report8-KFeb 9, 2026Feb 9, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 12, 2026SEC EDGAR
Current report8-KJan 7, 2026Jan 7, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 13, 2025SEC EDGAR
Current report8-KNov 13, 2025Nov 13, 2025SEC EDGAR
Current report8-KNov 11, 2025Nov 12, 2025SEC EDGAR
Current report8-KNov 4, 2025Nov 4, 2025SEC EDGAR
Current report8-KOct 30, 2025Oct 30, 2025SEC EDGAR
Current report8-KOct 27, 2025Oct 28, 2025SEC EDGAR
Current report8-KOct 22, 2025Oct 22, 2025SEC EDGAR
Current report8-KSep 30, 2025Oct 2, 2025SEC EDGAR